🕵️ Precision Biosciences Inc ($DTIL)
SEC insider & ownership activity, last 12 months · CIK 1357874 · every row links its SEC filing
Over the last 12 months insiders sold $466K against $54K of open-market buying. Amoroso Michael sold $246K through a 10b5-1 trading plan in 3 lots (Nov–Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $54K (5 lots) · 4 sellers, $466K (11 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Amoroso Michael | 0 | – | 3 | $246K | Feb 18, 2026 |
| Kelly John Alexander | 0 | – | 3 | $101K | Feb 18, 2026 |
| Smith J. Jefferson | 0 | – | 2 | $60K | Feb 18, 2026 |
| Scimeca Dario | 0 | – | 3 | $59K | Feb 18, 2026 |
| Frankel Stanley | 2 | $26K | 0 | – | Dec 16, 2025 |
| Geno J. Germano | 1 | $14K | 0 | – | Dec 16, 2025 |
| Brown Melinda | 2 | $14K | 0 | – | Dec 15, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 10.0% | 13G | Feb 10, 2026 | filing ↗ | |
| Octagon Investments Master Fund LP | 10.0% | 13G | Feb 10, 2026 | filing ↗ | |
| Ting Jia | 10.0% | 13G | Feb 10, 2026 | filing ↗ | |
| Matthew Smith | 9.4% | 13G | Aug 14, 2025 | filing ↗ | |
| Readout Capital, LP | 9.3% | 13G | Aug 14, 2025 | filing ↗ | |
| Readout Capital GP, LLC | 9.3% | 13G | Aug 14, 2025 | filing ↗ | |
| Aberdeen Group PLC | 8.9% | 13G | Jan 27, 2026 | filing ↗ | |
| Abrdn Inc. | 8.9% | 13G | Jan 27, 2026 | filing ↗ | |
| LYNX1 Capital Management LP | 8.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Weston Nichols | 8.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Bleichroeder LP | 8.2% | 13G | Feb 13, 2026 | filing ↗ | |
| Bleichroeder Holdings LLC | 8.2% | 13G | Feb 13, 2026 | filing ↗ | |
| Andrew Gundlach | 8.2% | 13G | Feb 13, 2026 | filing ↗ | |
| ROC Holdings SPV II, LP | 7.6% | 13G | Aug 14, 2025 | filing ↗ | |
| Readout Holdings GP, LLC | 7.6% | 13G | Aug 14, 2025 | filing ↗ | |
| LYNX1 Capital Management LP | 5.4% | 13G | Jul 20, 2026 | filing ↗ | |
| Weston Nichols | 5.4% | 13G | Jul 20, 2026 | filing ↗ | |
| Weinstein Benjamin | 5.2% | 13G | Mar 18, 2025 | filing ↗ | |
| Empery Asset Management, LP | exited | 13G | Jul 29, 2026 | filing ↗ | |
| Ryan M. Lane | exited | 13G | Jul 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Smith J. Jefferson | $19K | Feb 18, 2026 | filing ↗ |
| Scimeca Dario | $19K | Feb 18, 2026 | filing ↗ |
| Amoroso Michael | $79K | Feb 18, 2026 | filing ↗ |
| Kelly John Alexander | $31K | Feb 18, 2026 | filing ↗ |
| Amoroso Michael | $145K | Jan 22, 2026 | filing ↗ |
| Scimeca Dario | $36K | Jan 21, 2026 | filing ↗ |
| Smith J. Jefferson | $41K | Jan 21, 2026 | filing ↗ |
| Kelly John Alexander | $61K | Jan 21, 2026 | filing ↗ |
| Kelly John Alexander | $8K | Nov 3, 2025 | filing ↗ |
| Amoroso Michael | $22K | Nov 3, 2025 | filing ↗ |
| Scimeca Dario | $4K | Nov 3, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 1, 2026 | filing ↗ |
| Other events (8.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 27, 2026 | filing ↗ |
| Other events (8.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 21, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Other events (8.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Nov 10, 2025 | filing ↗ |